2,965
Views
60
CrossRef citations to date
0
Altmetric
Review

Exosomes in cancer theranostic: Diamonds in the rough

, , , , , & show all
Pages 151-163 | Received 15 Aug 2016, Accepted 17 Oct 2016, Published online: 06 Feb 2017

References

  • Hurley JH, Boura E, Carlson L-A, Różycki B Membrane budding. Cell 2010; 143:875-87; PMID:21145455; http://dx.doi.org/10.1016/j.cell.2010.11.030
  • Marzesco A-M, Janich P, Wilsch-Bräuninger M, Dubreuil V, Langenfeld K, Corbeil D, Huttner WB Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J Cell Sci 2005; 118:2849-58; PMID:15976444; http://dx.doi.org/10.1242/jcs.02439
  • Borges FT, Reis LA, Schor N Extracellular vesicles: structure, function, and potential clinical uses in renal diseases. Braz J Med Biol Res Rev Bras Pesqui Médicas E Biológicas Soc Bras Biofísica 2013; Al 46:824-830.
  • Gasser O, Hess C, Miot S, Deon C, Sanchez J-C, Schifferli JA Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp Cell Res 2003; 285:243-57; PMID:12706119; http://dx.doi.org/10.1016/S0014-4827(03)00055-7
  • Trams EG, Lauter CJ, Salem N, Heine U Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta 1981; 645:63-70; PMID:6266476; http://dx.doi.org/10.1016/0005-2736(81)90512-5
  • Hawari FI, Rouhani FN, Cui X, Yu Z-X, Buckley C, Kaler M, Levine SJ Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. Proc Natl Acad Sci U S A 2004; 101:1297-302; PMID:14745008; http://dx.doi.org/10.1073/pnas.0307981100
  • Ristorcelli E, Beraud E, Verrando P, Villard C, Lafitte D, Sbarra V, Lombardo D, Verine A Human tumor nanoparticles induce apoptosis of pancreatic cancer cells. FASEB J Off Publ Fed Am Soc Exp Biol 2008; 22:3358-69.
  • Théry C, Boussac M, Véron P, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol Baltim Md 1950 2001; 166:7309-18.
  • Junquera C, Castiella T, Muñoz G, Fernández-Pacheco R, Luesma MJ, Monzón M Biogenesis of a new type of extracellular vesicles in gastrointestinal stromal tumors: ultrastructural profiles of spheresomes. Histochem. Cell Biol 2016
  • Théry C, Ostrowski M, Segura E Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009a; 9:581-93; http://dx.doi.org/10.1038/nri2567
  • Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W Exosomes in cancer: small particle, big player. J Hematol Oncol J Hematol Oncol 2015; 8:83; http://dx.doi.org/10.1186/s13045-015-0181-x
  • Soung YH, Nguyen T, Cao H, Lee J, Chung J. Emerging roles of exosomes in cancer invasion and metastasis. BMB Rep 2016; 49:18–25.
  • Campanella C, Bavisotto CC, Gammazza AM, Nikolic D, Rappa F, David S, Cappello F, Bucchieri F, Fais S Exosomal Heat Shock Proteins as New Players in Tumour Cell-to-cell Comm unication. J Circ Biomark 2014; 1; http://dx.doi.org/10.5772/58721
  • De Maio A, Vazquez D Extracellular heat shock proteins: a new location, a new function. Shock Augusta Ga 2013a; 40:239-246; http://dx.doi.org/10.1097/SHK.0b013e3182a185ab
  • Pan BT, Johnstone RM Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 1983; 33:967-78; PMID:6307529; http://dx.doi.org/10.1016/0092-8674(83)90040-5
  • Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 1987; 262:9412-20; PMID:3597417
  • Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996; 183:1161-72; PMID:8642258; http://dx.doi.org/10.1084/jem.183.3.1161
  • Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 1998; 4:594-600; PMID:9585234; http://dx.doi.org/10.1038/nm0598-594
  • van Niel G, Raposo G, Candalh C, Boussac M, Hershberg R, Cerf-Bensussan N, Heyman M Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 2001; 121:337-49; PMID:11487543; http://dx.doi.org/10.1053/gast.2001.26263
  • Fauré J, Lachenal G, Court M, Hirrlinger J, Chatellard-Causse C, Blot B, Grange J, Schoehn G, Goldberg Y, Boyer V, et al. Exosomes are released by cultured cortical neurones. Mol Cell Neurosci 2006; 31:642-8; http://dx.doi.org/10.1016/j.mcn.2005.12.003
  • Wolfers J, Lozier A, Raposo G, Regnault A, Théry C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 2001; 7:297-303; PMID:11231627; http://dx.doi.org/10.1038/85438
  • Taylor DD, Akyol S, Gercel-Taylor C Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol Baltim Md 2006; 1950 176:1534-42.
  • Caby M-P, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C. Exosomal-like vesicles are present in human blood plasma. Int Immunol 2005; 17:879–887.
  • Pisitkun T, Shen R-F, Knepper MA Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 2004; 101:13368-73; PMID:15326289; http://dx.doi.org/10.1073/pnas.0403453101
  • Ogawa Y, Kanai-Azuma M, Akimoto Y, Kawakami H, Yanoshita R Exosome-like vesicles with dipeptidyl peptidase IV in human saliva. Biol Pharm Bull 2008; 31:1059-62; PMID:18520029; http://dx.doi.org/10.1248/bpb.31.1059
  • Admyre C, Grunewald J, Thyberg J, Gripenbäck S, Tornling G, Eklund A, Scheynius A, Gabrielsson S Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur Respir J 2003; 22:578-83; PMID:14582906; http://dx.doi.org/10.1183/09031936.03.00041703
  • Gatti J-L, Métayer S, Belghazi M, Dacheux F, Dacheux J-L Identification, proteomic profiling, and origin of ram epididymal fluid exosome-like vesicles. Biol Reprod 2005; 72:1452-65; PMID:15635128; http://dx.doi.org/10.1095/biolreprod.104.036426
  • Keller S, Rupp C, Stoeck A, Runz S, Fogel M, Lugert S, Hager H-D, Abdel-Bakky MS, Gutwein P, Altevogt P CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int 2007; 72:1095-102; PMID:17700640; http://dx.doi.org/10.1038/sj.ki.5002486
  • Admyre C, Johansson SM, Qazi KR, Filén J-J, Lahesmaa R, Norman M, Neve EPA, Scheynius A, Gabrielsson S Exosomes with immune modulatory features are present in human breast milk. J Immunol Baltim Md 1950 2007; 179:1969-78.
  • Andre F, Schartz NEC, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet Lond Engl 2002; 360:295-305; http://dx.doi.org/10.1016/S0140-6736(02)09552-1
  • Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, Walsh TS, Chalmers RTA, Webb DJ, Dear JW Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med 2012; 10:5; PMID:22221959; http://dx.doi.org/10.1186/1479-5876-10-5
  • Duijvesz D, Luider T, Bangma CH, Jenster G Exosomes as biomarker treasure chests for prostate cancer. Eur Urol 2011; 59:823-31; PMID:21196075; http://dx.doi.org/10.1016/j.eururo.2010.12.031
  • Hurley JH ESCRT complexes and the biogenesis of multivesicular bodies. Curr Opin Cell Biol 2008; 20:4-11; PMID:18222686; http://dx.doi.org/10.1016/j.ceb.2007.12.002
  • Williams RL, Urbé S. The emerging shape of the ESCRT machinery. Nat Rev Mol Cell Biol 2007; 8:355–368.
  • Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brügger B, Simons M Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008; 319:1244-7; PMID:18309083; http://dx.doi.org/10.1126/science.1153124
  • Savina A, Furlán M, Vidal M, Colombo MI Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem 2003; 278:20083-90; PMID:12639953; http://dx.doi.org/10.1074/jbc.M301642200
  • Feng Z p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment. Cold Spring Harb Perspect Biol 2010; 2:a001057; PMID:20182617; http://dx.doi.org/10.1101/cshperspect.a001057
  • Hsu C, Morohashi Y, Yoshimura S-I, Manrique-Hoyos N, Jung S, Lauterbach MA, Bakhti M, Grønborg M, Möbius W, Rhee J, Barr FA, et al. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J Cell Biol 2010; 189:223-32; PMID:20404108; http://dx.doi.org/10.1083/jcb.200911018
  • Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 2010; 12:19-30-13; PMID:19966785; http://dx.doi.org/10.1038/ncb2000
  • Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, Ivarsson Y, Depoortere F, Coomans C, Vermeiren E, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 2012; 14:677-85; PMID:22660413; http://dx.doi.org/10.1038/ncb2502
  • Thompson CA, Purushothaman A, Ramani VC, Vlodavsky I, Sanderson RD Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. J Biol Chem 2013; 288:10093-9; PMID:23430739; http://dx.doi.org/10.1074/jbc.C112.444562
  • Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, Coscia C, Iessi E, Logozzi M, Molinari A, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 2009; 284:34211-22; PMID:19801663; http://dx.doi.org/10.1074/jbc.M109.041152
  • Crescitelli R, Lässer C, Szabó TG, Kittel A, Eldh M, Dianzani I, Buzás EI, Lötvall J Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles 2013; 2; PMID:24223256; http://dx.doi.org/10.3402/jev.v2i0.20677
  • Raposo G, Stoorvogel W Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013; 200:373-83; PMID:23420871; http://dx.doi.org/10.1083/jcb.201211138
  • Logozzi, M, et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PloS One 2009; 4:e5219.
  • Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, Dingli F, Loew D, Tkach M, Théry C Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci 2016; 113:E968-77; http://dx.doi.org/10.1073/pnas.1521230113
  • Hosseini-Beheshti E, Pham S, Adomat H, Li N, Tomlinson Guns ES. Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes. Mol Cell Proteomics 2012; MCP 11:863–885.
  • Ibrahim A, Marban E. Exosomes: Fundamental Biology and Roles in Cardiovascular Physiology. Annu Rev Physiol 2016; 78:67-83; PMID:26667071
  • Mittelbrunn M, Sánchez-Madrid F. Intercellular communication: diverse structures for exchange of genetic information. Nat Rev Mol Cell Biol 2012; 13:328–335.
  • Gobbo J, Marcion G, Cordonnier M, Dias AMM, Pernet N, Hammann A, Richaud S, Mjahed H, Isambert N, Clausse V, et al. Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer. J Natl Cancer Inst 2016; 108:; PMID:26598503; http://dx.doi.org/10.1093/jnci/djv330
  • Crunkhorn S. Cancer: Cancer exosomes promote tumorigenesis. Nat Rev Drug Discov 2015; 14:16–16.
  • Raimondo S, Corrado C, Raimondi L, De Leo G, Alessandro R. Role of Extracellular Vesicles in Hematological Malignancies. BioMed Res Int 2015; 2015:821613.
  • Yu, D. et al. Exosomes in development, metastasis and drug resistance of breast cancer. Cancer Sci 2015; 106:959–964.
  • Santé publique France - InVS / Accueil. Available at http://invs.santepubliquefrance.fr/ (Accessed: 4th November 2016)
  • Institut National Du Cancer - Accueil. Available at http://www.e-cancer.fr/ (Accessed: 4th November 2016)
  • Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari N, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 2015; 523:177-82; PMID:26106858; http://dx.doi.org/10.1038/nature14581
  • Gumireddy K, Li A, Chang DH, Liu Q, Kossenkov AV, Yan J, Korst RJ, Nam BT, Xu H, Zhang L, et al. AKAP4 is a circulating biomarker for non-small cell lung cancer. Oncotarget 2015; 6:17637-47; PMID:26160834; http://dx.doi.org/10.18632/oncotarget.3946
  • Madhavan B, Yue S, Galli U, Rana S, Gross W, Müller M, Giese NA, Kalthoff H, Becker T, Büchler MW, et al. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. Int. J. Cancer 2015; 136:2616-27.
  • Kalra H, Adda CG, Liem M, Ang C-S, Mechler A, Simpson RJ, Hulett MD, Mathivanan S Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma. Proteomics 2013; 13:3354-64; PMID:24115447; http://dx.doi.org/10.1002/pmic.201300282
  • Rolfo C, Castiglia M, Hong D, Alessandro R, Mertens I, Baggerman G, Zwaenepoel K, Gil-Bazo I, Passiglia F, Carreca AP, et al. Liquid biopsies in lung cancer: the new ambrosia of researchers. Biochim Biophys Acta 2014; 1846:539-46.
  • Riches A, Campbell E, Borger E, Powis S Regulation of exosome release from mammary epithelial and breast cancer cells – A new regulatory pathway. Eur J Cancer 2014; 50(5):1025-34.; PMID:24462375; http://dx.doi.org/10.1016/j.ejca.2013.12.019
  • Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar C, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012; 18:883-91; PMID:22635005; http://dx.doi.org/10.1038/nm.2753
  • Szajnik M, Derbis M, Lach M, Patalas P, Michalak M, Drzewiecka H, Szpurek D, Nowakowski A, Spaczynski M, Baranowski W, et al. Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy. Gynecol Obstet Sunnyvale Calif Suppl 2013; 4:3
  • Pinet S, Bessette B, Vedrenne N, Lacroix A, Richard L, Jauberteau M-O, Battu S & Lalloué F. TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells. Oncotarget 2016; 7:6349-50364; PMID:27385098
  • Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S, Burlet-Schiltz O, Larue L, Muller C, et al. Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines. Pigment Cell Melanoma Res 2015; 28:464-75; PMID:25950383; http://dx.doi.org/10.1111/pcmr.12380
  • Alegre E, Zubiri L, Perez-Gracia JL, González-Cao M, Soria L, Martín-Algarra S, González A Circulating melanoma exosomes as diagnostic and prognosis biomarkers. Clin Chim Acta 2016; 454:28-32; PMID:26724367; http://dx.doi.org/10.1016/j.cca.2015.12.031
  • Hoshino A, Costa-Silva B, Shen T-L, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, et al. Tumour exosome integrins determine organotropic metastasis. Nature 2015; 527:329-35; PMID:26524530; http://dx.doi.org/10.1038/nature15756
  • Li Y, Zhang Y, Qiu F, Qiu Z Proteomic identification of exosomal LRG1: a potential urinary biomarker for detecting NSCLC. Electrophoresis 2011; 32:1976-83; PMID:21557262; http://dx.doi.org/10.1002/elps.201000598
  • Sandfeld-Paulsen B, Jakobsen KR, Bæk R, Folkersen BH, Rasmussen TR, Meldgaard P, Varming K, Jørgensen MM, Sorensen BS. Exosomal Proteins as a Diagnostic Biomarkers in Lung Cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 2016; 11:1701-1710; http://dx.doi.org/10.1016/j.jtho.2016.05.034
  • Hong C-S, Muller L, Whiteside TL, Boyiadzis M Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia. Front Immunol 2014; 5:160; PMID:24782865; http://dx.doi.org/10.3389/fimmu.2014.00160
  • Khan S, Jutzy JMS, Valenzuela MMA, Turay D, Aspe JR, Ashok A, Mirshahidi S, Mercola D, Lilly MB, Wall NR Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. PloS One 2012; 7:e46737; PMID:23091600; http://dx.doi.org/10.1371/journal.pone.0046737
  • Li J, Sherman-Baust CA, Tsai-Turton M, Bristow RE, Roden RB, Morin PJ Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer 2009; 9:244; PMID:19619303; http://dx.doi.org/10.1186/1471-2407-9-244
  • Yoshioka Y, Kosaka N, Konishi Y, Ohta H, Okamoto H, Sonoda H, Nonaka R, Yamamoto H, Ishii H, Mori M, et al. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat Commun 2014; 5:3591; PMID:24710016; http://dx.doi.org/10.1038/ncomms4591
  • Huang S-H, Li Y, Zhang J, Rong J, Ye S Epidermal growth factor receptor-containing exosomes induce tumor-specific regulatory T cells. Cancer Invest 2013; 31:330-5; PMID:23614656; http://dx.doi.org/10.3109/07357907.2013.789905
  • Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654-9; PMID:17486113; http://dx.doi.org/10.1038/ncb1596
  • Esquela-Kerscher A, Slack FJ Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-69; PMID:16557279; http://dx.doi.org/10.1038/nrc1840
  • Melo SA, Sugimoto H, O'Connell JT, Kato N, Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell 2014; 26:707-21; PMID:25446899; http://dx.doi.org/10.1016/j.ccell.2014.09.005
  • Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, Yu Y, Chow A, O'Connor STF, Chin AR, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 2014; 25:501-15; PMID:24735924; http://dx.doi.org/10.1016/j.ccr.2014.03.007
  • Chiam K, Wang T, Watson DI, Mayne GC, Irvine TS, Bright T, Smith L, White IA, Bowen JM, Keefe D, et al. Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma. J Gastrointest Surg Off J Soc Surg Aliment Tract 2015; 19:1208-15; http://dx.doi.org/10.1007/s11605-015-2829-9
  • Munagala R, Aqil F, Gupta RC. Exosomal miRNAs as biomarkers of recurrent lung cancer. Tumour Biol J Int Soc Oncodevelopmental Biol Med 2016; http://dx.doi.org/10.1007/s13277-016-4939-8
  • Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008; 110:13–21.
  • André F, Chaput N, Schartz NEC, Flament C, Aubert N, Bernard J, Lemonnier F, Raposo G, Escudier B, Hsu D-H, et al. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J Immunol Baltim Md 1950 2004; 172:2126-36.
  • Yang Y, Xiu F, Cai Z, Wang J, Wang Q, Fu Y, Cao X Increased induction of antitumor response by exosomes derived from interleukin-2 gene-modified tumor cells. J Cancer Res Clin Oncol 2007; 133:389-99; PMID:17219198; http://dx.doi.org/10.1007/s00432-006-0184-7
  • Zhang Y, Luo C-L, He B-C, Zhang J-M, Cheng G, Wu X-H Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma. Int J Oncol 2010; 36:133-40; PMID:19956842
  • Chaput N, Schartz NEC, André F, Taïeb J, Novault S, Bonnaventure P, Aubert N, Bernard J, Lemonnier F, Merad M, et al. Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J Immunol Baltim Md 1950 2004; 172:2137-46
  • Zeelenberg IS, Ostrowski M, Krumeich S, Bobrie A, Jancic C, Boissonnas A, Delcayre A, Le Pecq J-B, Combadière B, Amigorena S, et al. Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses. Cancer Res 2008; 68:1228-35; PMID:18281500; http://dx.doi.org/10.1158/0008-5472.CAN-07-3163
  • Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, Li G Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther J Am Soc Gene Ther 2008; 16:782-90; http://dx.doi.org/10.1038/mt.2008.1
  • Besse B, Charrier M, Lapierre V, Dansin E, Lantz O, Planchard D, Le Chevalier T, Livartoski A, Barlesi F, Laplanche A, et al. Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology 2016; 5:e1071008; PMID:27141373; http://dx.doi.org/10.1080/2162402X.2015.1071008
  • van den Boorn JG, Schlee M, Coch C, Hartmann G SiRNA delivery with exosome nanoparticles. Nat Biotechnol 2011; 29:325-6; PMID:21478846; http://dx.doi.org/10.1038/nbt.1830
  • Lee J, Kim J, Jeong M, Lee H, Goh U, Kim H, Kim B, Park J-H Liposome-Based Engineering of Cells To Package Hydrophobic Compounds in Membrane Vesicles for Tumor Penetration. Nano Lett 2015; 15:2938-44; PMID:25806671; http://dx.doi.org/10.1021/nl5047494
  • Srivastava A, Babu A, Filant J, Moxley KM, Ruskin R, Dhanasekaran D, Sood AK, McMeekin S, Ramesh R Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer. J Biomed Nanotechnol 2016; 12:1159-73; PMID:27319211; http://dx.doi.org/10.1166/jbn.2016.2205
  • Johnsen KB, Gudbergsson JM, Skov MN, Pilgaard L, Moos T, Duroux M A comprehensive overview of exosomes as drug delivery vehicles — Endogenous nanocarriers for targeted cancer therapy. Biochim Biophys Acta BBA - Rev Cancer 2014; 1846:75-87; http://dx.doi.org/10.1016/j.bbcan.2014.04.005
  • Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R, Yin VP, Lockman P, Bai S Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm Res 2015; 32:2003-14; PMID:25609010; http://dx.doi.org/10.1007/s11095-014-1593-y
  • Pascucci L, Coccè V, Bonomi A, Ami D, Ceccarelli P, Ciusani E, Vigan∫ L, Locatelli A, Sisto F, Doglia SM, Parati E, Bernardo ME, Muraca M, Alessandri G, Bondiolotti G & Pessina A Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release Off J Control Release Soc 2014; 192:262-70; http://dx.doi.org/10.1016/j.jconrel.2014.07.042
  • Saari H, Lázaro-Ibáñez E, Viitala T, Vuorimaa-Laukkanen E, Siljander P, Yliperttula M Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J Control Release Off J Control Release Soc 2015; 220:727-37; http://dx.doi.org/10.1016/j.jconrel.2015.09.031
  • Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ, Wei J, Nie G A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 2014; 35:2383-90; PMID:24345736; http://dx.doi.org/10.1016/j.biomaterials.2013.11.083
  • Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release Off J Control Release Soc 2015; 205:35-44; http://dx.doi.org/10.1016/j.jconrel.2014.11.029
  • Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, Liu C, Barnes S, Grizzle W, Miller D, Zhang H-G A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther J Am Soc Gene Ther 2010; 18:1606-14; http://dx.doi.org/10.1038/mt.2010.105
  • Mizrak A, Bolukbasi MF, Ozdener GB, Brenner GJ, Madlener S, Erkan EP, Ströbel T, Breakefield XO, Saydam O Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth. Mol Ther J Am Soc Gene Ther 2013; 21:101-8; http://dx.doi.org/10.1038/mt.2012.161
  • Pace, A. et al. Hsp60, a novel target for antitumor therapy: structure-function features and prospective drugs design. Curr Pharm Des 2013; 19:2757–2764.
  • Akerfelt M, Morimoto RI, Sistonen L Heat shock factors: integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol 2010; 11:545-55; PMID:20628411; http://dx.doi.org/10.1038/nrm2938
  • Beckmann RP, Mizzen LE, Welch WJ Interaction of Hsp 70 with newly synthesized proteins: implications for protein folding and assembly. Science 1990; 248:850-4; PMID:2188360; http://dx.doi.org/10.1126/science.2188360
  • Gething MJ, Sambrook J Protein folding in the cell. Nature 1992; 355:33-45; PMID:1731198; http://dx.doi.org/10.1038/355033a0
  • Lanneau D, Wettstein G, Bonniaud P, Garrido C Heat shock proteins: cell protection through protein triage. ScientificWorldJournal 2010; 10:1543-52; PMID:20694452; http://dx.doi.org/10.1100/tsw.2010.152
  • Lanneau D, de Thonel A, Maurel S, Didelot C, Garrido C Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27. Prion 2007; 1:53-60; PMID:19164900; http://dx.doi.org/10.4161/pri.1.1.4059
  • De Maio A Extracellular Hsp70: export and function. Curr Protein Pept Sci 2014; 15:225-31; PMID:24694368; http://dx.doi.org/10.2174/1389203715666140331113057
  • Multhoff G, Botzler C, Wiesnet M, Müller E, Meier T, Wilmanns W, Issels RD A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer 1995; 61:272-9; PMID:7705958; http://dx.doi.org/10.1002/ijc.2910610222
  • Liao W-C, Wu M-S, Wang H-P, Tien Y-W, Lin J-T Serum heat shock protein 27 is increased in chronic pancreatitis and pancreatic carcinoma. Pancreas 2009; 38:422-6; PMID:19214136; http://dx.doi.org/10.1097/MPA.0b013e318198281d
  • De Maio A, Vazquez D Extracellular heat shock proteins: a new location, a new function. Shock Augusta Ga 2013b; 40:239-46; http://dx.doi.org/10.1097/SHK.0b013e3182a185ab
  • Sidera K, Patsavoudi E Extracellular HSP90: conquering the cell surface. Cell Cycle Georget Tex 2008; 7:1564-8; http://dx.doi.org/10.4161/cc.7.11.6054
  • Campanella C, Bucchieri F, Merendino AM, Fucarino A, Burgio G, Corona DFV, Barbieri G, David S, Farina F, Zummo G, et al. The odyssey of Hsp60 from tumor cells to other destinations includes plasma membrane-associated stages and Golgi and exosomal protein-trafficking modalities. PloS One 2012; 7:e42008; PMID:22848686; http://dx.doi.org/10.1371/journal.pone.0042008
  • Schorey JS, Bhatnagar S Exosome function: from tumor immunology to pathogen biology. Traffic Cph Den 2008; 9:871-81; http://dx.doi.org/10.1111/j.1600-0854.2008.00734.x
  • Théry C, Ostrowski M, Segura E Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009b; 9:581-93; http://dx.doi.org/10.1038/nri2567
  • Blagosklonny MV Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs. Leukemia 2002; 16:455-62; PMID:11960322; http://dx.doi.org/10.1038/sj.leu.2402415
  • Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle Georget Tex 2006; 5:2592-601.
  • Neckers L, Ivy SP Heat shock protein 90. Curr Opin Oncol 2003; 15:419-24; PMID:14624223; http://dx.doi.org/10.1097/00001622-200311000-00003
  • Sun J, Liao JK Induction of Angiogenesis by Heat Shock Protein 90 Mediated by Protein Kinase Akt and Endothelial Nitric Oxide Synthase. Arterioscler Thromb Vasc Biol 2004; 24:2238-44; PMID:15486309; http://dx.doi.org/10.1161/01.ATV.0000147894.22300.4c
  • Calderwood SK, Gong J Heat Shock Proteins Promote Cancer: It's a Protection Racket. Trends Biochem Sci 2016; 41:311-23; PMID:26874923; http://dx.doi.org/10.1016/j.tibs.2016.01.003
  • Gibert B, Eckel B, Gonin V, Goldschneider D, Fombonne J, Deux B, Mehlen P, Arrigo A-P, Clézardin P, Diaz-Latoud C Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo. Br J Cancer 2012; 107:63-70; PMID:22627320; http://dx.doi.org/10.1038/bjc.2012.188
  • Gong J, Weng D, Eguchi T, Murshid A, Sherman MY, Song B, Calderwood SK Targeting the hsp70 gene delays mammary tumor initiation and inhibits tumor cell metastasis. Oncogene 2015; 34:5460-71; PMID:25659585; http://dx.doi.org/10.1038/onc.2015.1
  • Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin J-P, Boireau W, Rouleau A, Simon B, Lanneau D, et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest 2010; 120:457-71; PMID:20093776
  • Tamura Y, Torigoe T, Kutomi G, Hirata K, Sato N New paradigm for intrinsic function of heat shock proteins as endogenous ligands in inflammation and innate immunity. Curr Mol Med 2012; 12:1198-206; PMID:22804242; http://dx.doi.org/10.2174/156652412803306710.
  • Gastpar R, Gehrmann M, Bausero MA, Asea A, Gross C, Schroeder JA, Multhoff G Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res 2005; 65:5238-47; PMID:15958569; http://dx.doi.org/10.1158/0008-5472.CAN-04-3804
  • Vega VL, Rodríguez-Silva M, Frey T, Gehrmann M, Diaz JC, Steinem C, Multhoff G, Arispe N, De Maio A Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages. J Immunol Baltim Md 1950 2008; 180:4299-307
  • De Maio A Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage. It is never known how far a controversial finding will go! Dedicated to Ferruccio Ritossa. Cell Stress Chaperones 2011; 16:235-49; PMID:20963644; http://dx.doi.org/10.1007/s12192-010-0236-4
  • Chen W, Wang J, Shao C, Liu S, Yu Y, Wang Q, Cao X Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells. Eur J Immunol 2006; 36:1598-607; PMID:16708399; http://dx.doi.org/10.1002/eji.200535501
  • Xie Y, Bai O, Zhang H, Yuan J, Zong S, Chibbar R, Slattery K, Qureshi M, Wei Y, Deng Y, et al. Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70. J Cell Mol Med 2010; 14:2655-66; PMID:19627400; http://dx.doi.org/10.1111/j.1582-4934.2009.00851.x
  • Lv L-H, Wan Y-L, Lin Y, Zhang W, Yang M, Li G-L, Lin H-M, Shang C-Z, Chen Y-J, Min J Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro. J Biol Chem 2012; 287:15874-85; PMID:22396543; http://dx.doi.org/10.1074/jbc.M112.340588
  • Stangl S, Varga J, Freysoldt B, Trajkovic-Arsic M, Siveke JT, Greten FR, Ntziachristos V, Multhoff G Selective in vivo imaging of syngeneic, spontaneous, and xenograft tumors using a novel tumor cell-specific hsp70 peptide-based probe. Cancer Res 2014; 74:6903-12; PMID:25300920; http://dx.doi.org/10.1158/0008-5472.CAN-14-0413
  • McCready J, Sims JD, Chan D, Jay DG Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer 2010; 10:294; PMID:20553606; http://dx.doi.org/10.1186/1471-2407-10-294
  • WO2015/189395. “HSP70 peptide aptamers: Methods and compositions for diagnosis, monitoring and treating cancer.”
  • Campanella C, Rappa F, Sciumè C, Marino Gammazza A, Barone R, Bucchieri F, David S, Curcurù G, Caruso Bavisotto C, et al. Heat shock protein 60 levels in tissue and circulating exosomes in human large bowel cancer before and after ablative surgery. Cancer 2015; 121:3230-9; PMID:26060090; http://dx.doi.org/10.1002/cncr.29499

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.